{
    "clinical_study": {
        "@rank": "70385", 
        "arm_group": {
            "arm_group_label": "Radiotherapy", 
            "arm_group_type": "Other", 
            "description": "Single fraction radiotherapy"
        }, 
        "brief_summary": {
            "textblock": "This is a survey study to evaluate the feasibility and effectiveness of an affordable, $400\n      flat rate, same-day consultation, simulation, and delivery of a single fraction of\n      palliative radiation therapy for patients with symptomatic bony metastatic disease who are\n      currently enrolled in hospice. Treatment planning and delivery of palliative radiotherapy\n      will utilize \"standard of care\" techniques."
        }, 
        "brief_title": "Compassionate Same-Day Evaluation & Delivery of XRT for Bony Metastasis in Hospice Patients", 
        "completion_date": {
            "#text": "June 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Symptomatic Osseous Bone Lesions From Any Malignancy", 
        "condition_browse": {
            "mesh_term": [
                "Neoplasms", 
                "Neoplasm Metastasis"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Symptomatic osseous bone lesion(s) from any malignancy, whether primary of\n             metastatic, with histological confirmation of malignancy.\n\n          -  Currently enrolled in hospice and referred for single fraction palliative\n             radiotherapy.\n\n          -  Performance status (to be evaluated by the radiation oncologist), Karnofsky\n             Performance Scale  \u2265 20 or ECOG Performance Scale < 5 .\n\n          -  Ability to understand and willingness to sign a written informed consent document\n\n        Exclusion Criteria:\n\n          -  Pregnancy.\n\n          -  Unable to understand English.\n\n          -  Unable to complete forms with assistance.\n\n          -  Concurrent enrollment in a study of pain management involving medications or devices."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "21", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 20, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01760941", 
            "org_study_id": "MCC-14596", 
            "secondary_id": "NCI-2012-03117"
        }, 
        "intervention": {
            "arm_group_label": "Radiotherapy", 
            "description": "Single fraction radiotherapy", 
            "intervention_name": "Radiotherapy", 
            "intervention_type": "Radiation", 
            "other_name": "Single fraction radiotherapy"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "No", 
        "keyword": [
            "Urology", 
            "Prostate", 
            "Breast", 
            "Lung", 
            "Chest"
        ], 
        "lastchanged_date": "December 18, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Richmond", 
                    "country": "United States", 
                    "state": "Virginia", 
                    "zip": "23298"
                }, 
                "name": "Virginia Commonwealth University/Massey Cancer Center"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "Feasibility of a Compassionate Same-Day Evaluation and Delivery of Single Fraction Radiotherapy for Palliation of Symptomatic Bony Metastasis in Hospice Patients", 
        "other_outcome": {
            "description": "Quantify the percentage of patients receiving the treatment who believe that the treatment was worthwhile", 
            "measure": "Quantify the percentage of patients receiving the treatment who believe that the treatment was worthwhile", 
            "safety_issue": "No", 
            "time_frame": "6 months"
        }, 
        "overall_official": {
            "affiliation": "Virginia Commonwealth University", 
            "last_name": "Drew Moghanaki, MD, MPH", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Suspended", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Patient evaluation will consist of surveys conducted at the time of treatment  measured by the Radiation Oncologist Evaluation and Feasibility Assessments survey", 
            "measure": "Feasibility of treatment delivery in the same day as initial evaluation", 
            "safety_issue": "No", 
            "time_frame": "Up to 6 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01760941"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Evaluate the treatment influence on the rate of pain stabilization and/or reduction as measured by the validated BPI patient questionnaire.", 
                "measure": "Evaluate the treatment influence on the rate of pain stabilization and/or reduction", 
                "safety_issue": "No", 
                "time_frame": "2 weeks"
            }, 
            {
                "description": "Evaluate the treatment influence on patient quality of life as measured by the ESAS.", 
                "measure": "Evaluate the treatment influence on patient quality of life", 
                "safety_issue": "No", 
                "time_frame": "2 weeks"
            }
        ], 
        "source": "Virginia Commonwealth University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Virginia Commonwealth University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2013", 
        "study_design": "Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Supportive Care", 
        "study_type": "Interventional", 
        "verification_date": "December 2013", 
        "why_stopped": "focus on raising awareness in the community about the program then re-open study"
    }
}